BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
2076
DELISTED
ChemoCentryx, Inc.
CCXI
| $339K | ﹤0.01% |
13,687
-70,168
| -84% | -$1.74M |
|
2077
PROS Holdings
PRO
$699M
| $338K | ﹤0.01% |
12,880
+6,168
| +92% | +$162K |
|
2078
iShares MSCI United Kingdom ETF
EWU
$2.93B
| $338K | ﹤0.01% |
11,273
-9,756
| -46% | -$292K |
|
2079
Amplify Junior Silver Miners ETF
SILJ
$2.28B
| $338K | ﹤0.01% |
35,510
-10,565
| -23% | -$100K |
|
2080
Philips
PHG
$26.8B
| $337K | ﹤0.01% |
17,629
-210,033
| -92% | -$4.02M |
|
2081
Enova International
ENVA
$2.88B
| $336K | ﹤0.01% |
11,642
-2,313
| -17% | -$66.7K |
|
2082
Global X Silver Miners ETF NEW
SIL
$3.19B
| $335K | ﹤0.01% |
12,947
-8,257
| -39% | -$214K |
|
2083
LSB Industries
LXU
$576M
| $335K | ﹤0.01% |
24,184
+24,183
| +2,418,300% | +$335K |
|
|
MYOV
2084
DELISTED
Myovant Sciences Ltd.
MYOV
| $335K | ﹤0.01% |
26,952
-45,557
| -63% | -$566K |
|
|
FUV
2085
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $334K | ﹤0.01% |
5,103
+4,971
| +3,766% | +$325K |
|
2086
NewMarket
NEU
$7.87B
| $333K | ﹤0.01% |
1,107
-251
| -18% | -$75.5K |
|
2087
CRISPR Therapeutics
CRSP
$5.12B
| $332K | ﹤0.01% |
5,469
-16,424
| -75% | -$998K |
|
|
KBAL
2088
DELISTED
Kimball International
KBAL
| $332K | ﹤0.01% |
43,231
-42,543
| -50% | -$326K |
|
2089
CNA Financial
CNA
$12.9B
| $330K | ﹤0.01% |
7,349
+379
| +5% | +$17K |
|
2090
NeoGenomics
NEO
$1.03B
| $327K | ﹤0.01% |
40,146
+7,268
| +22% | +$59.2K |
|
2091
Astec Industries
ASTE
$1.06B
| $326K | ﹤0.01% |
7,984
-334
| -4% | -$13.6K |
|
|
NTUS
2092
DELISTED
Natus Medical Inc
NTUS
| $325K | ﹤0.01% |
9,920
-2,385
| -19% | -$78.2K |
|
2093
Pacific Biosciences
PACB
$351M
| $325K | ﹤0.01% |
73,440
+24,890
| +51% | +$110K |
|
2094
Columbia Financial
CLBK
$1.6B
| $323K | ﹤0.01% |
14,831
-4,792
| -24% | -$105K |
|
|
ADAM
2095
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $322K | ﹤0.01% |
29,182
-5,539
| -16% | -$61.2K |
|
2096
Ameresco
AMRC
$1.44B
| $321K | ﹤0.01% |
7,054
+4,248
| +151% | +$194K |
|
|
PGTI
2097
DELISTED
PGT, Inc.
PGTI
| $321K | ﹤0.01% |
19,284
-2,614
| -12% | -$43.5K |
|
|
RWT
2098
Redwood Trust
RWT
$804M
| $321K | ﹤0.01% |
41,607
-589
| -1% | -$4.54K |
|
2099
Frontline
FRO
$5.17B
| $321K | ﹤0.01% |
36,187
+19,891
| +122% | +$176K |
|
|
MRTX
2100
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $320K | ﹤0.01% |
4,765
-22,382
| -82% | -$1.5M |
|